# A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down

> **NCT02388373** · PHASE4 · COMPLETED · sponsor: **Research in Real-Life Ltd** · enrollment: 225 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone 250/formoterol 10
- **DRUG:** Fluticasone 250/salmeterol 25
- **DRUG:** Fluticasone 125/formoterol 5

## Key facts

- **NCT ID:** NCT02388373
- **Lead sponsor:** Research in Real-Life Ltd
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2016-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02388373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02388373, "A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02388373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*